Your new post is loading...
Institute of Bioengineering and Nanotechnology (IBN) researchers have engineered an artificial human liver that mimics the natural tissue environment closely.
The development makes it possible for companies to predict the toxicity of new drugs earlier, potentially speeding up the drug development process and reducing the cost of manufacturing
